Transgene expands myvac platform into non-small cell lung cancer with TG4070
Replicate Bioscience awarded Gates Foundation grant to advance srRNA vaccine candidates for TB
Bavarian Nordic secures DKK700m government vaccine contract
Anixa secures Canadian patent milestone for ovarian cancer vaccine
Transgene to present preclinical TG-MVA mpox vaccine data at World Congress on Infectious Diseases
4basebio secures clinical supply agreement for Phase II immunotherapy trial
GSK's Arexvy gains expanded approval in Japan for at-risk adults aged 18-49
Bavarian Nordic secures USD97m US vaccine contract expansion and raises 2026 outlook
Anixa Biosciences reports extended survival signals in Phase 1 ovarian cancer CAR-T trial
4basebio introduces enzymatic ssDNA platform for gene editing applications
hVIVO secures Phase III human challenge trial contract with ILiAD Biotechnologies
Sanofi's Nuvaxovid demonstrates superior tolerability to Moderna's mNEXSPIKE in phase 4 study
hVIVO signs influenza human challenge trial agreement with Traws Pharma
Delonix Bioworks launches Phase 1 trial of next-generation MenB OMV vaccine DX-104